Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 22, 2026
Reporting period
Not applicable
Filed with the SEC
May 27, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001689392-26-000008
Filed / recorded
May 27, 2026, 8:10 PM UTC
Added to OQRO
Oct 2, 2026, 12:29 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
ZIMMER BIOMET HOLDINGS, INC.
Issuer CIK
1136869
Ticker
ZBH
Reporting person
Sreelakshmi Kolli
Relationship
Director
Security
Restricted Stock Units
Table
Derivative (Table II)
Transaction date
May 22, 2026
Transaction code
A
Shares / units
1,517.274
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
6,875
Ownership form
Direct
Amendment
No
Footnotes from the filing
The Conversion or Exercise Price of Derivative Security is 1-for-1.
The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.